血中ステロイドホルモンのプロファイルと,メチラポンからオシロドロスタットに移行した後の臨床結果
Kei Yokozeki1, Hiraku Kameda1, Aika Miya1
1Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido 060-8638, Japan.
Endocrine journal
|August 31, 2025
まとめ
クッシング病の患者でメチラポンからオシロドロスタットに切り替えると,臨床結果とホルモンプロファイルが改善された. オシロドロスタットはCYP17A1の活性を抑制し,不十分な病気のコントロールに潜在的な利点を示唆しました.
科学分野:
- 内分泌学
- 薬理学について
背景:
- カッシング病はメチラポンやオシロドロスタットなどのステロイド生成阻害剤で治療されます.
- オシロドロスタットはメチラポンより効果があるかもしれないが,臨床実務における差異は報告されていない.
研究 の 目的:
- メチラポンからオシロドロスタットに切り替えられた患者におけるステロイドホルモンプロファイルと臨床結果の評価.
- オシロドロスタットとメチラポンの有効性と安全性を臨床試験で比較する
主な方法:
- 7人のクッシング病患者はメチラポンからオシロドロスタットに移行した.
- 高性能液体染色体質スペクトロメトリーで測定されたステロイドホルモン濃度.
- 薬剤,症状,ホルモンレベルを含む臨床的結果が評価されました.
主要な成果:
- オシロドロスタットへの移行後,有害事象は報告されていません.
- カリウムとACTHの有意な増加; デヒドロエピアンドロステロン硫酸とテストステロンの減少.
- 17Preg/Pregと17Prog/Progの比率の低下によって示された.
- 臨床的改善には高血圧の低下,男性化の減少,胃の不快感の緩和が含まれています.
結論:
- オシロドロスタットは,メチラポンと比べて,クッシング病の治療において,より優れたCYP17A1阻害をもたらす可能性がある.
- オシロドロスタットへの移行は,不十分な病気のコントロールと特定の合併症の患者にとって有益である.
- 異なる酵素阻害パターンは,観察された臨床結果の違いを説明します.
関連する概念動画
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
201
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
201
COPD: Management Using Bronchodilators and Corticosteroids
305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
Nephrotic Syndrome II : Assessment and Medical Management
21
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
21
Blood Studies for Cardiovascular System III: Serum Lipid Profile
291
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
291
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
Hypertension III: Clinical Manifestations and Diagnostic Studies
48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48


